Liminatus Pharma Inc (LIMN) concluded trading on Thursday at a closing price of $20.31, with 3.2 million shares of worth about $64.91 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 91.42% during that period and on June 12, 2025 the price saw a gain of about 82.81%. Currently the company’s common shares owned by public are about 7.07M shares, out of which, 2.02M shares are available for trading.
Stock saw a price change of -17.44% in past 5 days and over the past one month there was a price change of 209.29%. Year-to-date (YTD), LIMN shares are showing a performance of 81.02% which increased to 99.90% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $4.40 but also hit the highest price of $26.68 during that period. The average intraday trading volume for Liminatus Pharma Inc shares is 214.95K. The stock is currently trading 88.73% above its 20-day simple moving average (SMA20), while that difference is up 111.09% for SMA50 and it goes to 94.77% higher than SMA200.
Liminatus Pharma Inc (NASDAQ: LIMN) currently have 7.07M outstanding shares and institutions hold larger chunk of about 1.75% of that.
The stock has a current market capitalization of $528.35M and its 3Y-monthly beta is at 0.27. It has posted earnings per share of -$0.40 in the same period. It has Quick Ratio of 0.09. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for LIMN, volatility over the week remained 54.04% while standing at 33.05% over the month.
